AlTi Global’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.1M Buy
305,061
+373
+0.1% +$30.1K 0.5% 31
2026
Q1
$26.6M Sell
304,688
-102
-0% -$9.77K 0.58% 26
2025
Q4
$29.5M Buy
304,790
+44
+0% +$4.27K 0.63% 23
2025
Q3
$29.2M Buy
304,746
+1,348
+0.4% +$124K 0.69% 22
2025
Q2
$26.7M Buy
303,398
+205
+0.1% +$17.4K 0.67% 22
2025
Q1
$27.2M Buy
303,193
+601
+0.2% +$53.8K 0.71% 21
2024
Q4
$24.2M Buy
302,592
+199
+0.1% +$17.2K 0.58% 23
2024
Q3
$27.2M Buy
302,393
+299,764
+11,402% +$25.2M 0.65% 22
2024
Q2
$209K Sell
2,629
-760
-22% -$62.3K 0.01% 364
2024
Q1
$298K Buy
+3,389
New +$289K 0.01% 313

Other funds holding MDT

AlTi Global's MDT Position: Q2 2026 in Review

AlTi Global increased its Medtronic (MDT) stake by 0.12% in Q2 2026, buying an estimated $30.1K and bringing the position to 305,061 shares worth $24.1M. The position accounts for 0.5% of the portfolio, ranked #31.

AlTi Global first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $29.5M in Q4 2025. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • AlTi Global held 305,061 shares of Medtronic worth $24.1M as of Q2 2026.
  • AlTi Global bought 373 Medtronic shares in Q2 2026, an estimated $30.1K.
  • Medtronic made up 0.5% of AlTi Global's portfolio in Q2 2026, its #31 holding.
  • AlTi Global first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • AlTi Global's Medtronic position peaked at $29.5M in Q4 2025.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.